SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed the intimation for loss of share certificate.01-12-2020
01-12-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the details of related party transactions on consolidated basis for the half year ended September 30, 2020 in the format specified in the relevant accounting standards for annual results. This is for your information and record.01-12-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation for issue of duplicate share certificate25-11-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 20, 2020 for Shanghvi Finance Pvt Ltd20-11-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of Record Date For Redemption Of Commercial Paper
Please find enclosed Intimation of Record Date for Redemption of Commercial Paper18-11-2020
Buy Sun Pharmaceutical Industries; target of Rs 597: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 597 in its research report dated November 04, 2020.06-11-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 06, 2020 for Shanghvi Finance Pvt Ltd06-11-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2020 for Raksha Sudhir Valia05-11-2020
Buy Sun Pharmaceutical Industries: target of Rs 612: Sharekhan
Sharekhan is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 612 in its research report dated November 03, 2020.05-11-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2020 for Aditya Medisales Ltd05-11-2020